A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas

CHIA-CHI LINArkenau H.-T.Lu S.Sachdev J.de Castro Carpe?o J.Mita M.Dziadziuszko R.Su W.-C.Bobilev D.Hughes L.Chan J.Zhang Z.-Y.Weiss G.J.2022-09-152022-09-1520190007-0920https://www.scopus.com/inward/record.uri?eid=2-s2.0-85067863153&doi=10.1038%2fs41416-019-0503-9&partnerID=40&md5=fe030e7231a9003034dca91cb1bab43ahttps://scholars.lib.ntu.edu.tw/handle/123456789/620254A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomasjournal article10.1038/s41416-019-0503-9312174792-s2.0-85067863153